Search research articles
Contact Us
Filters
Showing results (101-110 of 139) with videos related to
Page
of 14
Sort By:
Reviews of Environmental Contamination and Toxicology
|
December 29, 2016
Modelling the Release, Transport and Fate of Engineered Nanoparticles in the Aquatic Environment - A Review
Adriaan A Markus, John R Parsons, Erwin W M Roex, et al.
The Science of the Total Environment
|
December 3, 2014
Modeling aggregation and sedimentation of nanoparticles in the aquatic environment
A A Markus, J R Parsons, E W M Roex, et al.
Water Research
|
January 23, 2016
Modelling the transport of engineered metallic nanoparticles in the river Rhine
A A Markus, J R Parsons, E W M Roex, et al.
Journal of Molecular Biology
|
January 10, 1998
The RNA binding domain of ribosomal protein L11: three-dimensional structure of the RNA-bound form of the protein and its interaction with 23 S rRNA
A P Hinck, M A Markus, S Huang, et al.
Journal of Biomolecular NMR
|
January 31, 2004
1H, 13C, and 15N backbone assignments and secondary structure for the 60.8 kD dimer of the NAD+ synthetase from Bacillus subtilis
Michelle A Markus, Lisa Doliveira, Karl Malakian, et al.
The Science of the Total Environment
|
April 18, 2013
Predicting the contribution of nanoparticles (Zn, Ti, Ag) to the annual metal load in the Dutch reaches of the Rhine and Meuse
A A Markus, J R Parsons, E W M Roex, et al.
Journal of Biomolecular NMR
|
April 2, 2005
1H, 13C, and 15N assignments of MMP-12, a key protease implicated in lung tissue remodeling
Michelle A Markus, Brian Dwyer, Scott Wolfrom, et al.
Journal of Biomolecular NMR
|
April 22, 2008
Solution structure of wild-type human matrix metalloproteinase 12 (MMP-12) in complex with a tight-binding inhibitor
Michelle A Markus, Brian Dwyer, Scott Wolfrom, et al.
The Journal of Antimicrobial Chemotherapy
|
June 1, 1995
Chemotherapeutic activity of levofloxacin (HR 355, DR-3355) against systemic and localized infections in laboratory animals
N Klesel, K H Geweniger, P Koletzki, et al.
The Journal of Antibiotics
|
April 1, 1992
RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. I. Antibacterial activity in vitro
A Bauernfeind, R Jungwirth, E Eberlein, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 139) with videos related to
Sort By:
Page
of 14
Reviews of Environmental Contamination and Toxicology
|
December 29, 2016
Modelling the Release, Transport and Fate of Engineered Nanoparticles in the Aquatic Environment - A Review
Adriaan A Markus, John R Parsons, Erwin W M Roex, et al.
The Science of the Total Environment
|
December 3, 2014
Modeling aggregation and sedimentation of nanoparticles in the aquatic environment
A A Markus, J R Parsons, E W M Roex, et al.
Water Research
|
January 23, 2016
Modelling the transport of engineered metallic nanoparticles in the river Rhine
A A Markus, J R Parsons, E W M Roex, et al.
Journal of Molecular Biology
|
January 10, 1998
The RNA binding domain of ribosomal protein L11: three-dimensional structure of the RNA-bound form of the protein and its interaction with 23 S rRNA
A P Hinck, M A Markus, S Huang, et al.
Journal of Biomolecular NMR
|
January 31, 2004
1H, 13C, and 15N backbone assignments and secondary structure for the 60.8 kD dimer of the NAD+ synthetase from Bacillus subtilis
Michelle A Markus, Lisa Doliveira, Karl Malakian, et al.
The Science of the Total Environment
|
April 18, 2013
Predicting the contribution of nanoparticles (Zn, Ti, Ag) to the annual metal load in the Dutch reaches of the Rhine and Meuse
A A Markus, J R Parsons, E W M Roex, et al.
Journal of Biomolecular NMR
|
April 2, 2005
1H, 13C, and 15N assignments of MMP-12, a key protease implicated in lung tissue remodeling
Michelle A Markus, Brian Dwyer, Scott Wolfrom, et al.
Journal of Biomolecular NMR
|
April 22, 2008
Solution structure of wild-type human matrix metalloproteinase 12 (MMP-12) in complex with a tight-binding inhibitor
Michelle A Markus, Brian Dwyer, Scott Wolfrom, et al.
The Journal of Antimicrobial Chemotherapy
|
June 1, 1995
Chemotherapeutic activity of levofloxacin (HR 355, DR-3355) against systemic and localized infections in laboratory animals
N Klesel, K H Geweniger, P Koletzki, et al.
The Journal of Antibiotics
|
April 1, 1992
RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. I. Antibacterial activity in vitro
A Bauernfeind, R Jungwirth, E Eberlein, et al.
Page
of 14